Tryp Therapeutics
Tryp Therapeutics is leading psychedelic drug development beyond mental health.
-
Greg McKee, Chairman and Chief Executive Officer, Tryp Therapeutics.
Greg has served in executive management positions for more than 20 years. He started his career in life sciences with Genzyme before serving as Chairman and CEO of publicly traded Nventa Biopharmaceuticals. Greg also served as CEO of CONNECT, a startup accelerator, and as Co-founder and Managing Director of Torrent Ventures. Greg earned a BA in economics from the University of Washington, an MA in international studies from the University of Pennsylvania and an MBA from the Wharton School. He has worked in Tokyo for seven years and has been a member of YPO since 2006.
